Micronutrients in pregnancy: Current knowledge and unresolved questions

Clinical Nutrition

Volumn 30, Issue 6, 2011, Pages 689-701

  Berti, C ^a   Biesalski, H K ^b   Gartner R ^c   Lapillonne, A ^d,e   Pietrzik, K ^f   Poston, L ^g   Redman, C ^h   Koletzko, B ^c   Cetin, I ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF BONN   (Germany)

^g KING'S COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Liposoluble vitamins; Minerals; One carbon metabolism; Oxidative inflammation stress; Pregnancy

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; IODINE; IRON; PLACEBO; RETINOL; SELENIUM; THYROXINE; TRACE ELEMENT; VITAMIN D;

AUTOIMMUNE THYROIDITIS; CONGENITAL HEART DISEASE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; DRUG URINE LEVEL; ENZYME ACTIVITY; FETAL WELL BEING; FETUS DEVELOPMENT; HEALTH HAZARD; HEALTH STATUS; HIGH RISK PREGNANCY; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; IODINE DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON OVERLOAD; MATERNAL MORTALITY; MATERNAL NUTRITION; METABOLIC SYNDROME X; NEURAL TUBE DEFECT; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OPTIMAL DRUG DOSE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PUBLIC HEALTH SERVICE; RECOMMENDED DRUG DOSE; RETINOL DEFICIENCY; REVIEW; RICKETS; RISK REDUCTION; SELENIUM DEFICIENCY; TERATOGENICITY; THYROXINE BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EATING; FEMALE; HUMANS; MICRONUTRIENTS; PREGNANCY;

EID: 82255191741     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.08.004     Document Type: Review

References (178)

1. Biesalski H.K. The significance of vitamin A for the development and function of the lung. Forum Nutr 2003, 56:37-40.
2. Doyle W., Srivastava A., Crawford M.A., Bhatti R., Brooke Z., Costeloe K.L. Inter-pregnancy folate and iron status of women in an inner-city population. Brit J Nutr 2001, 86:81-87.
3. Shohaimi S., Bingham S., Welch A., Luben R., Day N., Wareham N., et al. Occupational social class, educational level and area deprivation independently predict plasma ascorbic acid concentration: a cross-sectional population based study in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk). Eur J Clin Nutr 2004, 58:1432-1435.
4. Bates C.J., Prentice A., Cole T.J., van der Pols J.C., Doyle W., Finch S., et al. Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. Brit J Nutr 1999, 82:7-15.
5. Darmon N., Drewnowski A. Does social class predict diet quality?. Am J Clin Nutr 2008, 87:1107-1117.
6. Cetin I., Berti C., Calabrese S. Role of micronutrients in the periconceptional period. Hum Reprod Update 2010, 16:80-95.
7. Berti C., Decsi T., Dykes F., Hermoso M., Koletzko B., Massari M., et al. Critical issues in setting micronutrient recommendations for pregnant women: an insight. Matern Child Nutr 2010, 6:5S-22S.
8. Thomas M., Weisman S.M. Calcium supplementation during pregnancy and lactation: effects on the mother and the fetus. Am J Obstet Gynecol 2006, 194:937-945.
9. Pitkin R.M. Folate and neural tube defects. Am J Clin Nutr 2007, 85:285S-288S.
10. McArdle H.J., Ashworth C.J. Micronutrients in fetal growth and development. Br Med Bull 1999, 55:499-510.
11. FAO/WHO Report. Vitamin and mineral requirements in human nutrition 2004, World Health Organization and Food and Agriculture Organization of the United Nations. 2nd ed.
12. Pietrzik K., Golly I., Loew D. Handbuch Vitamine 2008, Elsevier Urban & Fischer.
13. Greene N.D., Stanier P., Copp A.J. Genetics of human neural tube defects. Hum Mol Genet 2009, 18:R113-R129.
14. Locksmith G.J., Duff P. Preventing neural tube defects: the importance of periconceptional folic acid supplements. Obstet Gynecol 1998, 91:1027-1034.
15. Guéant J.L., Guéant-Rodriguez R.M., Anello G., Bosco P., Brunaud L., Romano C., et al. Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and down syndrome?. Clin Chem Lab Med 2003, 41:1473-1477.
16. Obeid R., Herrmann W. Homocysteine, folic acid and vitamin B12 in relation to pre- and postnatal health aspects. Clin Chem Lab Med 2005, 43:1052-1057.
17. Sadananda Adiga M.N., Chandy S., Ramaswamy G., Appaji L., Aruna Kumari B.S., Krishnamoorthy L. Association between plasma homocysteine and riboflavin status in acute lymphoblastic leukemia in children. Indian J Clin Biochem 2009, 24:257-261.
18. Dhillon V., Thomas P., Fenech M. Effect of common polymorphisms in folate uptake and metabolism genes on frequency of micronucleated lymphocytes in a South Australian cohort. Mutat Res 2009, 665:1-6.
19. de Bree A., Verschuren W.M., Bjørke-Monsen A.L., van het Hof K.H., Steegers-heunissen R.P.M. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003, 77:687-693.
20. Blom H.J. Folic acid, methylation and neural tube closure in humans. Birth Def Res (Part A) 2009, 85:295-302.
21. Prevention of neural tube defects: results of the Medical research Council vitamin study. Lancet 1991, 338:131-137. MRC Vitamin Study Research Group.
22. Czeizel A.E., Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
23. Czeizel A.E., Dudás I., Métneki J. Pregnancy outcomes in a randomised controlled trial of periconceptional multivitamin supplementation. Final report. Arch Gynecol Obstet 1994, 255:131-139.
24. Czeizel A.E., Dobó M., Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Def Res (Part A) 2004, 70:853-861.
25. Daly L.E., Kirke P.N., Molloy A., Weir D.G., Scott J.M. Folate levels and neural tube defects. Implication for prevention. JAMA 1995, 274:1698-1702.
26. Thamm M. Folsäureversorgung von Frauen im gebärfähigen Alter. Berliner Ärzte 2001, 8:21-24.
27. Pietrzik K., Prinz-Langenohl R., Lamers Y., Wintergerst E.S., Brämswig S. Randomized, placebo-controlled, double-blind study evaluating the effectiveness of a folic acid containing multivitamin supplement in increasing erythrocyte folate levels in young women of child-bearing age. Ann Nutr Metab 2005, 6.7.29 S.368.
28. Lamers Y., Prinz-Langenohl R., Brämswig S., Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr 2006, 84:156-161.
29. Shaw G.M., Carmichael S.L., Nelson V., Selvin S., Schaffer D.M. Occurrence of low birthweight and preterm delivery among California infants before and after compulsory food fortification with folic acid. Public Health Rep 2004, 119:170-173.
30. Nelen W.L., Blom H.J., Steegers E.A., den Heijer M., Thomas C.M., Eskes T.K. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000, 95:519-524.
31. Vollset S.E., Refsum H., Irgens L.M., Emblem B.M., Tverdal A., Gjessing H.K., et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland homocysteine Study. Am J Clin Nutr 2000, 71:962-968.
32. El-Khairy L., Vollset S.E., Refsum H., Ueland P.M. Plasma total cysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland homocysteine study. Am J Clin Nutr 2003, 77:467-472.
33. Steegers-Theunissen R.P., Van Iersel C.A., Peer P.G., Nelen W.L., Steegers E.A. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet Gynecol 2004, 104:336-343.
34. Mills J.L., McPartlin J.M., Kirke P.N., Lee J.L., Conley M.R., Weir D.G. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995, 345:149-151.
35. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998, 316:894-898. Homocysteine Lowering Trialists' Collaboration.
36. Clarke R., Refsum H., Birks J., Evans J.G., Johnston C., Sherliker P., et al. Screening for vitamin B12 and folate deficiency in older persons. Am J Clin Nutr 2003, 77:1241-1247.
37. Van der Put N.M.J., Eskes T.K.A.B., Blom H.J. Is the common 677C→T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis. QJMed 1997, 90:111-115.
38. Van der Molen E.F., Arends G.E., Nelen W.L., van der Put N.J., Heil S.G., Eskes T.K., et al. A common mutation in the 5,10-MTHFR gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol 2000, 182:1258-1263.
39. Nurk E., Tell G.S., Refsum H., Ueland P.M., Vollset S.E. Associations between maternal MTHFR polymorphisms and adverse outcomes of pregnancy: the Hordoland homocysteine study. Am J Med 2004, 117:26-31.
40. Mtiraoui N., Zammiti W., Ghazouani L., Braham N.J., Saidi S., Finan R.R., et al. MTHFR C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses. Reproduction 2006, 131:395-401.
41. McNulty H., Scott J.M. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008, 99:S48-S54.
42. Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intake; Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline 1998, Institute of Medicine, National Academy Press, Washington, DC.
43. Cuskelly G.J., Mooney K.M., Young I.S. Folate and vitamin B12: friendly or enemy nutrients for the elderly. Proc Nutr Soc 2007, 66:548-558.
44. Morris M.S., Jacques P.F., Rosenberg I.H., Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr 2010, 91:1733-1744.
45. Ulrich C.M., Potter J.D. Folate supplementation: too much of a good thing?. Cancer Epidemiol Biomarkers Prev 2006, 15:189-193.
46. Simmer K., James C., Thompson R.P.H. Are iron-folate supplements harmful?. Am J Clin Nutr 1987, 5:122-125.
47. Green T.J., Skeaff M., Whiting S.J., Gibson R.S. Effect of folic acid supplementation on plasma zinc concentrations of young women. Nutr 2003, 19:522-523.
48. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazura M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
49. Taylor C.T. Antioxidants and reactive oxygen species in human fertility. Envir Toxicol Pharmacol 2001, 10:189-198.
50. Agarwal A., Gupta S., Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005, 3:28. published online. 10.1186/1477-7827-3-28.
51. Agarwal A., Gupta S., Sekhon L., Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal 2008, 10:1375-1403.
52. Ruder E.H., Hartman T.J., Blumberg J., Goldman M.B. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update 2008, 14:345-357.
53. Grimble R.F. Nutritional modulation of cytokine biology. Nutr 1998, 14:634-640.
54. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999, 180:499-506.
55. Raijmakers M.T., Dechend R., Poston L. Oxidative stress and pre-eclampsia; rationale for antioxidant clinical trials. Hypertension 2004, 44:374-380.
56. Moffet A., Loke C. Immunology of placentation in eutherian mammals. Nat Rev 2006, 6:584-594.
57. Burton G.J., Hung T.-H. Hypoxia-reoxygenation; a potential source of placental oxidative stress in normal pregnancy and preeclampsia. Fet Mat Med Rev 2003, 14(2):97-117.
58. Fernández-Riejos P., Najib S., Santos-Alvarez J., Martín-Romero C., Pérez-Pérez A., González-Yanes C., et al. Role of leptin in the activation of immune cells. Mediators Inflamm 2010, 2010(568343).
59. Perkins A.V. Endogenous anti-oxidants in pregnancy and preeclampsia. Aust New Zealand J Obstetr Gynaecol 2006, 46:77-83.
60. Rasmussen K.M., Kjolhede C.L. Maternal obesity: a problem for both mother and child. Obesity 2008, 16:929-931.
61. Hauguel-de Mouzon S., Lepercq J., Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006, 194:1537-1545.
62. Ahima R.S., Flier R.J. Adipose tissue as an endocrine organ. TEM 2000, 11:327-332.
63. Sullivan D.R., Celermajer D.S., Le Couteur D.G., Lam CVk The vascular implications of post-prandial lipoprotein metabolism. Clin Biochem Rev 2004, 25:19-30.
64. Van Oostrom A.J.H.H.M., Sijmonsma T.P., Verseyden C., et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 2003, 44:576-583.
65. Hofmeyr G.J., Lawrie T.A., Atallah A.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010, 8. CD001059.
66. Teegarden D., Gunther C.W. Can the controversial relationship between dietary calcium and body weight be mechanistically explained by alterations in appetite and food intake?. Nutr Rev 2008, 66:601-605.
67. Fritsche K. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006, 26:45-73.
68. Horvath A., Koletzko B., Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr 2007, 98:253-259.
69. Olafsdottir A.S., Skuladottir G.V., Thorsdottir I., Hauksson A., Thorgeirsdottir H., Steingrimsdottir L. Relationship between high consumption of marine fatty acids in early pregnancy and hypertensive disorders in pregnancy. BJOG 2006, 113:301-309.
70. Chappell L.C., Seed P.T., Briley A.L., Kelly F.J., Lee R., Hunt B.J., et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999, 354:810-816.
71. Polyzos N.P., Mauri D., Tsappi M., Tzioras S., Kamposioras K., Cortinovis I., et al. Combined vitamin C and E supplementation during pregnancy for preeclampsia prevention: a systematic review. Obstet Gynecol Surv 2007, 62:202-206.
72. Poston L., Briley A.H., Seed P.T., Kelly F.J., Shennan A.H. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006, 367:1145-1154. for the Vitamins in Pre-eclampsia (VIP) consortium.
73. Reiter E., Jiang Q., Stephan Christen S. Anti-inflammatory properties of α- and γ-tocopherol. Mol Aspects Med 2007, 28:668-691.
74. Rumbold A.R., Crowther C.A., Haslam R.R., Dekker G.A., Robinson J.S. Vitamins C and E and the risks of pre-eclampsia and perinatal complications. NEJM 2006, 354:1796-1806. for the ACTS study group.
75. Villar J., Purwar M., Merialdi M., Zavaleta N., Thi Nhu Ngoc N., Anthony J., et al. World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG 2009, 116:780-788. on behalf of the WHO Vitamin C and Vitamin E trial group.
76. Roberts J.M., Myatt L., Spong C.Y., Thom E.A., Hauth J.C., Leveno K.J., et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010, 362:1282-1291. for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
77. Afzhal-Ahmed I., Mann C.E., Shennan A.H., Poston L., Naftalin R.J. Pre-eclampsia inactivates glucose-6-phopshate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med 2007, 42:1781-1790.
78. Rayman M.P., Bode P., Redman C.W.G. Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am J Obstet Gynecol 2003, 189:1343-1349.
79. Vanderlelie J., Venardos K., Clifton V.L., Gude N.M., Clarke F.M., Perkins A.V. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 2005, 26:53-58.
80. Mistry H.D., Wilson V., Ramsay M.M., Symonds M.E., Pipkin F.B. Reduced Selenium concentrations and glutathione peroxidase activity in preeclamptic pregnancies. Hypertension 2008, 52:881-888.
81. Vanderlelie J., Venardos K., Perkins A.V. Selenium deficiency as a model of experimental pre-eclampsia in rats. Reproduction 2004, 128:635-641.
82. Ross A.C. Vitamin A and carotenoids. Modern nutrition in health and disease 2006, 351-375. Lippincott Williams & Wilkins, USA. 10th ed. M.E. Shils, M. Shike, A.C. Ross (Eds.).
83. Grune T., Lietz G., Palou A., Ross A.C., Stahl W., Tang G., et al.β-Carotene is an important vitamin A source for humans. J Nutr 2010, 140:2268S-2285S.
84. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc 2001, Institute of Medicine (IOM), Food and Nutrition Board, National Academy Press, Washington, DC, available at:. http://www.nap.edu.
85. Dietary reference values (DRVs) for food energy and nutrients for the UK. Rep Health Soc Subjects 1991, 41. Panel on DRVs of the Committee on Medical Aspects of Food Policy (COMA).
86. Reference Values for Nutrient Intake (D-A-CH) 2000, D-A-CH German Nutrition Society, Austrian Nutrition Society, Swiss Society for Nutrition Research, Frankfurt am Main.
87. Shenai J.P., Chytil F., Stahlman M.T. Liver vitamin A reserve of very low birth weight neonates. Pediatr Res 1985, 19:892-893.
88. Shah R.S., Rajalakshmi R., Bhatt R.V., Hazra M.N., Patel B.C., Swamy N.B., et al. Liver stores of vitamin A in human fetuses in relation to gestational age, fetal size and maternal nutritional status. Br J Nutr 1987, 58:181-189.
89. Gazala E., Sarov B., Hershkovitz E., Edvardson S., Sklan D., Katz M., et al. Retinol concentration in maternal and cord serum: its relation to birth weight in healthy mother-infant pairs. Early Hum Develop 2003, 71:19-28.
90. Strobel M., Tinz J., Biesalski H.K. The importance of beta-carotene as a source of vitamin A with special regard to pregnant and breastfeeding women. Eur J Nutr 2007, 46:I/1-I/20.
91. Nutritional needs of preterm infants. Pediatric Nutrition Handbook 1998, 55-87. American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics, Elk Grove Village, IL. 4th ed. R.E. Kleinman (Ed.).
92. Schulz C., Engel U., Kreienberg L., Biesalski H.K. Vitamin A and beta-carotene supply of women with Gemini or short birth intervals. A pilot study. Eur J Nutr 2007, 46:12-20.
93. Verwendung von Vitaminen in Lebensmitteln 2004, Bundesinstitut für Risikobewertung (BfR), Berlin.
94. Biesalski H.K. Comparative assessment of the toxicology of vitamin A and retinoids in man. Toxicology 1989, 57:117-161.
95. Leung W.C., Hessel S., Méplan C., Flint J., Oberhauser V., Tourniaire F., et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J 2009, 23:1041-1053.
96. Azais-Bresco V., Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J Clin Nutr 2000, 71:1325-1333.
97. Almeras L., Eyles D., Benech P., Laffite D., Villard C., Patatian A., et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 2007, 7:769-780.
98. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009, 94:26-34.
99. Hewison M. Vitamin D and innate immunity. Curr Opin Investig Drugs 2008, 9:485-490.
100. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005, 135:317-322.
101. Hollis B.W., Wagner C.L. Normal serum vitamin D levels. N Engl J Med 2005, 352:515-516.
102. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D and Fluoride 1997, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine, National Academies Press, Washington, DC.
103. Vitamin D 2005, National Health and Medical Research Council of Australia, National Health Medical Research Council, available at:. http://www.nrv.gov.au/nutrients/vitamin%252520d.htm.
104. Healthy Start: Vitamin Supplement Recommendations 2008, United Kingdom Department of Health, United Kingdom Department of Health, London, available at:. http://www.healthystart.nhs.uk/en/fe/vitamin_supplement_recommendations.html.
105. Dietary Reference Intakes for Calcium and Vitamin D Nov. 2010, IOM.
106. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88:491S-499S.
107. Yetley E.A., Brulé D., Cheney M.C., Davis C.D., Esslinger K.A., Fischer P.W., et al. Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr 2009, 89:719-727.
108. Yetley E.A. Assessing the vitamin D status of the US population. Am J Clin Nutr 2008, 88:558S-564S.
109. Looker A.C., Pfeiffer C.M., Lacher D.A., Schleicher R.L., Picciano M.F., Yetley E.A. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88:1519-1527.
110. van der Meer I.M., Karamali N.S., Boeke A.J., Lips P., Middelkoop B.J., Verhoeven I., et al. High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 2006, 84:350-353.
111. Bodnar L.M., Simhan H.N., Powers R.W., Frank M.P., Cooperstein E., Roberts J.M. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007, 137:447-452.
112. Baker P.N., Wheeler S.J., Sanders T.A., Thomas J.E., Hutchinson C.J., Clarke K., et al. A prospective study of micronutrient status in adolescent pregnancy. Am J Clin Nutr 2009, 89:1114-1124.
113. Shin J.S., Choi M.Y., Longtine M.S., Nelson D.M. Vitamin D effects on pregnancy and the placenta. Placenta 2001, 31:1027-1034.
114. Kovacs C.S. Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 2008, 88:520S-528S.
115. Bodnar L.M., Catov J.M., Simhan H.N., Holick M.F., Powers R.W., Roberts J.M. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007, 92:3517-3522.
116. Halhali A., Villa A.R., Madrazo E., Soria M.C., Mercado E., Díaz L., et al. Longitudinal changes in maternal serum 1,25-dihydroxyvitamin D and insulin like growth factor I levels in pregnant women who developed preeclampsia: comparison with normotensive pregnant women. J Steroid Biochem Mol Biol 2004, 89-90:553-556.
117. Shaarawy M., Zaki S., Ramzi A.-M., Salem M.E., El-Minawi A.M. Feto-maternal bone remodeling in normal pregnancy and preeclampsia. J Soc Gynecol Investi 2005, 12:343-348.
118. Zhang C., Qiu C., Hu F.B., David R.M., van Dam R.M., Bralley A., et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE 2008, 3:e3753. published online. 10.1371/journal.pone.0003753.
119. Clifton-Bligh R.J., McElduff P., McElduff A. Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet Med 2008, 25:678-684.
120. Maghbooli Z., Hossein-Nezhad A., Karimi F., Shafaei A.R., Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008, 24:27-32.
121. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J Cell Biochem 2003, 88:327-331.
122. Cantorna M.T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80:1717S-1720S.
123. Evans K.N., Nguyen L., Chan J., Innes B.A. Effects of 25-Hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 2006, 75:816-822.
124. Saffery R., Ellis J., Morley R. A convergent model for placental dysfunction encompassing combined sub-optimal one-carbon donor and vitamin D bioavailability. Med Hypotheses 2009, 73:1023-1028.
125. Baker A.M., Haeri S., Camargo C.A., Espinola J.A., Stuebe A.M. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010, 95:5105-5109.
126. Powe C.E., Seely E.W., Rana S., Bhan I., Ecker J., Karumanchi S.A., et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010, 56:758.
127. Shand A., Nassar N., Von Dadelszen P., Innis S.M., Green T.J. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 2010, 117:1593-1598.
128. Peechakara S.V., Pittas A.G. Vitamin D as a potential modifier of diabetes risk. Nat Clin Pract Endocrinol Metab 2008, 4:182-183.
129. Teegarden D., Donkin S.S. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009, 22:82-92.
130. Chiu K.C., Chu A., Go V.L., Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79:820-825.
131. Salle B.L., Delvin E.E., Lapillonne A., Bishop N.J., Glorieux F.H. Perinatal metabolism of vitamin D. Am J Clin Nutr 2000, 71:1317S-1324S.
132. Krishnaveni G.V., Veena S.R., Winder N.R., Hill J.C., Noonan K., Boucher B.J., et al. Maternal vitamin D status during pregnancy and body composition and cardiovascular risk markers in Indian children: the Mysore Parthenon Study. Am J Clin Nutr 2011, 93:628-635.
133. Feron F., Burne T.H., Brown J., Smith E., McGrath J.J., Mackay-Sim A., et al. Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005, 65:141-148.
134. Kesby J.P., Burne T.H., McGrath J.J., Eyles D.W. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol Psychiatry 2006, 60:591-596.
135. Zipitis C.S., Akobeng A.K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008, 93:512-517.
136. Stene L.C., Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003, 78:1128-1134.
137. Camargo C.A., Rifas-Shiman S.L., Litonjua A.A., Rich-Edwards J.W., Weiss S.T., Gold D.R., et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 2007, 85:788-795.
138. Devereux G., Litonjua A.A., Turner S.W., Craig L.C., McNeill G., Martindale S., et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr 2007, 85:853-859.
139. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses 2010, 74:71-75.
140. Roth D.E. Vitamin D supplementation during pregnancy: safety considerations in the design and interpretation of clinical trials. J Perinatology 2011, 10.1038/jp.2010.203.
141. Milman N. Iron and pregnancy-a delicate balance. Ann Hematol 2006, 85:559-565.
142. Breymann C. Iron supplementation during pregnancy. Fet Mat Med Rev 2002, 13:1-29.
143. Lao T.T., Tham K.-F., Chan L.Y. Third trimester iron status and pregnancy outcome in non-anemic women; pregnancy unfavourably affected by maternal iron excess. Hum Reprod 2000, 15:1843-1848.
144. Scholl T.O. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr 2005, 81:1218S-1222S.
145. Hindmarsh P.C., Geary M.P.P., Rodeck C.H., Jackson M.R., Kingdom J.C. Effect of early maternal iron stores on placental weight and structure. Lancet 2000, 356:719-723.
146. Allen L.H. Biological mechanisms that might underlie iron's effects on fetal growth and preterm birth. J Nutr 2001, 131:581S-589S.
147. Gambling L., Dunford S., Wallace D.I., Zuur G., Solanky N., Srai S.K., et al. Iron deficiency during pregnancy affects postnatal blood pressure in the rat. J Physiol 2003, 552(2):603-610.
148. Osendarp S.J.M., Murray-Kolb L.E., Black M.M. Case study on iron in mental development - in memory of John Beard (1947-2009). Nutr Rev 2010, 68:S48-S52.
149. Beard J. Iron deficiency alters brain development and functioning. J Nutr 2003, 133:1468S-1472S.
150. Beard J.L. Why iron deficiency is important in infant development. J Nutr 2008, 138:2534-2536.
151. Insel B.J., Schaefer C.A., McKeague I.W., Susser E.S., Brown A.S. Maternal iron deficiency and the risk of schizophrenia in offspring. Arch Gen Psychiatry 2008, 65:1136-1144.
152. Siega-Riz A.M., Hartzema A.G., Turnbull C., Thorp J., McDonald T., Cogswell M.E. The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: a randomized controlled trial. Am J Obstet Gynecol 2006, 194:512-519.
153. Allen L.H. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin Nutr 2000, 71:1280S-1284S.
154. Makrides M., Crowther C.A., Gibson R.A., Gibson R.S., Skeaff C.M. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 2003, 78:145-153.
155. Ziaei S., Mehrnia M., Faghihzadeh S. Iron status markers in nonanemic pregnant women with and without iron supplementation. Int Gynaecol Obstet 2008, 100:130-132.
156. Cogswell M.E., Parvanta I., Ickes L., Yip R., Brittenham G.M. Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr 2003, 78:773-781.
157. Milman N., Agger A.O., Nielsen O.J. Iron status markers and serum erythropoietin in 120 mothers and newborn infants. Effect of iron supplementation in normal pregnancy. Acta Obstet Gyecol Scand 1994, 73:200-204.
158. Ziaei S., Norrozi M., Faghihzadeh S., Jafarbegloo E. A randomised placebo-controlled trial to determine the effect of iron supplementation on pregnancy outcome in pregnant women with haemoglobin ≥ 13.2 g/dl. BJOG 2007, 114:684-688.
159. Paesano R., Pietropaoli M., Gessani S., Valenti P. The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia. Biochimie 2009, 91:44-51.
160. Casanueva E., Viteri F.E. Iron and oxidative stress in pregnancy. J Nutr 2003, 133:1700S-1708S.
161. Bo S., Menato G., Villois P., Gambino R., Cassader M., Cotrino I., et al. Iron supplementation and gestational diabetes in midpregnancy. Am J Obstet Gynecol 2009, 201:158.e1-158.e6.
162. Hurrell R.F., Reddy M.B., Burri J., Cook J.D. An evaluation of EDTA compounds for iron fortification of cereal-based foods. Br J Nutr 2000, 84:903-910.
163. Mehansho H. Iron fortification technology development: new approaches. J Nutr 2006, 136:1059-1063.
164. Biebinger R., Zimmermann M.B., Al-Hooti S.N., Al-Hamed N., Al-Salem E., Zafar T., et al. Efficacy of wheat-based biscuits fortified with microcapsules containing ferrous sulfate and potassium iodate or a new hydrogen-reduced elemental iron: a randomised, double-blind, controlled trial in Kuwaiti women. Br J Nutr 2009, 102:1362-1369.
165. Glinoer D. The importance of iodine nutrition during pregnancy. Public Health Nutr 2007, 10(12A):1542-1546.
166. Zimmermann M.B. Iodine deficiency. Endocr Rev 2009, 30:376-408.
167. Becker D.V., Braverman L.E., Delange F., Dunn J.T., Franklyn J.A., Hollowell J.G., et al. Iodine supplementation for pregnancy and lactation - United States and Canada: recommendations of the American thyroid association. Thyroid 2006, 16:949-951.
168. Morreale de Escobar G., Obregon M.J., Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004, 151(Suppl. 3):U25-U37.
169. Morreale de Escobar G., Obregón M.J., Escobar del Rey F. Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr 2007, 10:1554-1570.
170. Alvarez-Pedrerol M., Guxens M., Mendez M., Canet Y., Martorell R., Espada M., et al. Iodine levels and thyroid hormones in healthy pregnant women and birth weight of their offspring. Eur J Endocrinol 2009, 160:423-429.
171. Santiago-Fernandez P., Torres-Barahona R., Muela-Martínez J.A., Rojo-Martínez G., García-Fuentes E., Garriga M.J., et al. Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab 2004, 89:3851-3857.
172. Gärtner R. Thyroid disease in pregnancy. Curr Opin Obstet Gynecol 2009, 21:501-507.
173. Orito Y., Oku H., Kubota S., Amino N., Shimogaki K., Hata M., et al. Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development. J Clin Endocrinol Metab 2009, 94:1683-1688.
174. Lazarus J.H. Thyroid function in pregnancy. Br Bull Med 2010.
175. Köhrle J., Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23:815-827.
176. Negro R., Greco G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007, 92:1263-1268.
177. Integrating nutrition and physical activity 2004, Nordic Nutrition Recommendations (NNR), Nordic Council of Ministers, Copenhagen. 4th ed.
178. Fairweather-Tait S.J., Bao Y., Broadley M.R., Collings R., Ford D., Hesketh J.E., et al. Selenium in human health and disease. Antioxid Redox Signal 2011, 14:1337-1383.